Detection of NRAS mutation in cell-free DNA biological fluids from patients with kaposiform lymphangiomatosis.

Orphanet J Rare Dis 2019 Sep 11;14(1):215. Epub 2019 Sep 11.

Department of Pediatrics, Graduate School of Medicine, Gifu University, Yanagido 1-1, Gifu, 501-1194, Japan.

Background: Kaposiform lymphangiomatosis (KLA) has recently been distinguished as a novel subtype of generalized lymphatic anomaly (GLA) with foci of spindle endothelial cells. All cases of KLA involve multiple organs and have an unfavorable prognosis. However, the molecular pathogenesis is unknown, and there are no useful biomarkers. In the present study, we performed genetic analysis to elucidate the cause of this disease and detect biomarkers for it.

Methods: We performed whole-exome sequencing of DNA samples from leukocytes and a biopsy specimen and analyzed cell-free DNA (cfDNA) from plasma and pleural effusion of patients to identify the NRAS c.182A > G (p.Q61R) mutation using the droplet digital polymerase chain reaction (ddPCR).

Results: All KLA patients (patients 1-5) had invasive and aggressive features (hemorrhagic pleural effusions, coagulation disorder, and thrombocytopenia) and characteristic findings of KLA in their pathological examinations. In whole exome sequencing for patient 1, c.182A > G missense variant (p.Q61R) in NRAS was identified in fresh frozen samples of a mass on the left chest wall at a frequency of 5% of total alleles but not in his blood leukocytes. Furthermore, the same mutation was detected in cfDNA isolated from plasma and pleural effusion by using ddPCR. ddPCR analysis of plasma/pleural effusion samples from an additional four KLA patients showed that the same mutation was detected in isolated cfDNA in three of the four, as well as in a tissue sample from one of the three plasma/effusion-positive patients that had been obtained to confirm the mutation.

Conclusion: These results provide the first evidence that NRAS oncogenic variant was identified in DNA samples from KLA patients from not only two affected lesions but also plasma and pleural effusion.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13023-019-1191-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737666PMC
September 2019
1 Read

Publication Analysis

Top Keywords

pleural effusion
12
plasma pleural
12
kla patients
12
dna samples
8
cell-free dna
8
mutation detected
8
kaposiform lymphangiomatosis
8
patients
7
kla
6
thrombocytopenia characteristic
4
characteristic findings
4
coagulation disorder
4
hemorrhagic pleural
4
features hemorrhagic
4
pleural effusions
4
effusions coagulation
4
findings kla
4
disorder thrombocytopenia
4
pathological examinations
4
c182a > g missense
4

References

(Supplied by CrossRef)

M Ozeki et al.
Pediatr Blood Cancer 2016

SE Croteau et al.
J Pediatr 2014

AK Greene et al.
Plast Reconstr Surg 2018

SF Barclay et al.
Genet Med 2019

E Manevitz-Mendelson et al.
Angiogenesis. 2018

RB Corcoran et al.
N Engl J Med 2018

A McKenna et al.
Genome Res 2010

K Wang et al.
Nucleic Acids Res 2010

TD Cras Le et al.
Angiogenesis 2017

Similar Publications